Expression of concern

MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

Paper Information

Record ID:
52502
Author(s):
Michela Garofalo
Cristina Quintavalle
G Di Leva
Ciro Zanca
Giulia Romano
Cristian Taccioli
Chang Gong Liu
Carlo M Croce
Gerolama Condorelli
Journal:
Oncogene ( Springer - Nature Publishing Group )
Publication Date:
February 04, 2008
Retraction Date:
February 28, 2024 (1.7 year years ago)
Subjects:
Broad Categories:
Biology Genetics
Institutions:
Countries:
🇮🇹 Italy 🇺🇸 United States
Article Type:
Research Article
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
DOI:
10.1038/onc.2008.6
PubMed ID:
18246122
Retraction PubMed ID:
38418545

Expression of concern Details

Retraction Reasons:
Nature of Retraction:

Expression of concern

Retraction Notice:
10.1038/s41388-024-02989-3

Citations (296)

296
Total Citations
5
Post-Retraction
(1.7%)
288
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
3 Within 1 year
0 After 2+ years
497 Days since retraction (latest)
Research progress on the relationship between lung cancer drug-resistance and microRNAs
Xuan Ma, Ai‐Ling Liang, Yongjun Liu
Journal of Cancer Open Access
Published: Jan 2019
21 citations
1884 days before retraction
<i>Retracted</i>: Effects of ebv‐miR‐BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non‐small cell lung cancer
Lei Wang, Li‐fa Liu, Li Zhou et al. (5 authors)
Journal of Cellular Biochemistry Open Access
Published: Dec 2018
8 citations
1897 days before retraction
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
Valentina Russo, Alessia Paciocco, Alessandra Affinito et al. (14 authors)
Molecular Therapy — Nucleic Acids Open Access
Published: Sep 2018
51 citations
1980 days before retraction
Progesterone up-regulates p27 through an increased binding of the progesterone receptor-A-p53 protein complex onto the non-canonical p53 binding motif in HUVEC
Sung‐Po Hsu, Po‐Han Lin, Chih‐Ming Chou et al. (4 authors)
The Journal of Steroid Biochemistry and Molecular Biology
Published: Aug 2018
9 citations
2015 days before retraction
Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma
Hongqian Liu, Bofeng Cao, Yuanyuan Zhao et al. (5 authors)
Cancer Biomarkers
Published: May 2018
19 citations
2108 days before retraction
miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC)
Yichao Han, Xiaomin He
Journal of Thoracic Disease Open Access
Published: May 2018
48 citations
2129 days before retraction
Clinical significance of blood‑based miRNAs as biomarkers of non‑small cell lung cancer (Review)
Lin Li, Yu Sun, Min Feng et al. (5 authors)
Oncology Letters Open Access
Published: Apr 2018
21 citations
2148 days before retraction
Importância de Dicer na progressão do melanoma e na resistência ao tratamento quimioterápico.
Nathália Cruz de Victo
Unknown Journal Open Access
Published: Mar 2018
2177 days before retraction
Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies
Xiaohong Du, Jitai Zhang, Juping Wang et al. (5 authors)
Current Pharmaceutical Design
Published: Feb 2018
67 citations
2207 days before retraction
Kanserde MikroRNA’lar ve İlaç Yanıtı
Çiğdem Aydın, Şükriye YEŞİLOT
SDÜ Tıp Fakültesi Dergisi Open Access
Published: Feb 2018
2 citations
2218 days before retraction
MicroRNAs as Biomarkers for Lung Cancer
William C. Cho
Elsevier eBooks
Published: Jan 2018
2249 days before retraction
miR‑221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells
Dan Liao, Tong Li, Caiguo Ye et al. (9 authors)
Experimental and Therapeutic Medicine Open Access
Published: Nov 2017
48 citations
2295 days before retraction
Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer
Mariangela Manicone, Cristina Poggiana, Antonella Facchinetti et al. (4 authors)
Journal of Thoracic Disease Open Access
Published: Oct 2017
21 citations
2341 days before retraction
Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer
Yilun Sun, Peter G. Hawkins, Nan Bi et al. (14 authors)
International Journal of Radiation Oncology*Biology*Physics Open Access
Published: Sep 2017
35 citations
2368 days before retraction
miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling
Shanshan Wang, Feng Lu, Baoguang Hu et al. (11 authors)
Molecular Therapy — Nucleic Acids Open Access
Published: Aug 2017
26 citations
2399 days before retraction
Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines, and this effect is partially abrogated by intraoperative radiation therapy treatment
Karolina Zaleska, Anna Przybyła, Katarzyna Kulcenty et al. (7 authors)
Oncology Letters Open Access
Published: Aug 2017
17 citations
2400 days before retraction
Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer
Kentaro Inamura
Cells Open Access
Published: May 2017
84 citations
2486 days before retraction
Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells
Xiao Zhang, Xiang Zhang, Shijie Hu et al. (13 authors)
Nucleic Acids Research Open Access
Published: Apr 2017
65 citations
2507 days before retraction
Withdrawn: The effects of MiR-223 on the sensitivity of non-small cell lung cancer cells to erlotinib and its underlying mechanisms
Xiaoyuan Du, Zhijing Wang, Xia Liu et al. (5 authors)
Saudi Pharmaceutical Journal Open Access
Published: Apr 2017
2524 days before retraction
Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance
Wei Meng, Yan Tai, Hui Zhao et al. (11 authors)
Medical Science Monitor Open Access
Published: Mar 2017
42 citations
2542 days before retraction
Macrophage-derived apoptotic bodies promote the proliferation of the recipient cells via shuttling microRNA-221/222
Ziwen Zhu, Duo Zhang, Heedoo Lee et al. (7 authors)
Journal of Leukocyte Biology Open Access
Published: Mar 2017
99 citations
2548 days before retraction
miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives
Mateusz Florczuk, Adam Szpechciński, Joanna Chorostowska‐Wynimko
Targeted Oncology Open Access
Published: Feb 2017
97 citations
2557 days before retraction
The role of exosomes and miRNAs in drug‐resistance of cancer cells
Duc‐Hiep Bach, Ji‐Young Hong, Hyen Joo Park et al. (4 authors)
International Journal of Cancer Open Access
Published: Feb 2017
257 citations
2557 days before retraction
Downregulation of miR-222 Induces Apoptosis and Cellular Migration in Adenoid Cystic Carcinoma Cells
Ziliang Zhou, Lijie Zhou, Fangfang Jiang et al. (7 authors)
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics Open Access
Published: Jan 2017
15 citations
2589 days before retraction
Correction: c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity
C Quintavalle, Mariarosaria Incoronato, Loredana Puca et al. (10 authors)
Cell Death and Differentiation Open Access
Published: Jan 2017
26 citations
2595 days before retraction
MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer
Giuseppina Roscigno, Ilaria Puoti, Immacolata Giordano et al. (11 authors)
Oncotarget Open Access
Published: Jan 2017
81 citations
2612 days before retraction
Expression of MicroRNAs in Thyroid Carcinoma
Gaohong Zhu, Lijun Xie, Daniel Miller
Methods in molecular biology
Published: Jan 2017
18 citations
2614 days before retraction
High miRNA-221 expression is associated with poor overall survival in patients with non-small cell lung cancer
Ya Liu, Jing Wang
Biomedical Research-tokyo
Published: Jan 2017
2 citations
2614 days before retraction
MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance
Yuanzhang Fang, Lu Zhang, Zhenghu Li et al. (6 authors)
International review of cell and molecular biology
Published: Jan 2017
18 citations
2614 days before retraction
Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.
Marta Geretto, Alessandra Pulliero, Camillo Rosano et al. (6 authors)
PubMed
Published: Jan 2017
89 citations
2614 days before retraction
Role of phytochemicals in the modulation of miRNA expression in cancer
Trishna Debnath, Narayan Chandra Deb Nath, Eun‐Kyung Kim et al. (4 authors)
Food & Function
Published: Jan 2017
46 citations
2614 days before retraction
MiR-222 in Cardiovascular Diseases: Physiology and Pathology
Shengguang Ding, Haitao Huang, Yiming Xu et al. (5 authors)
BioMed Research International Open Access
Published: Jan 2017
49 citations
2614 days before retraction
A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis
Xin Zhou, Wei Wen, Xia Shan et al. (15 authors)
Oncotarget Open Access
Published: Dec 2016
162 citations
2619 days before retraction
microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma
Xiao-yan He, Zheng-lan Tan, Qin Mou et al. (14 authors)
Clinical Cancer Research Open Access
Published: Dec 2016
36 citations
2624 days before retraction
TP53/MicroRNA Interplay in Hepatocellular Carcinoma
Daniela Pollutri, Laura Gramantieri, Luigi Bolondi et al. (4 authors)
International Journal of Molecular Sciences Open Access
Published: Dec 2016
33 citations
2644 days before retraction
Exosomes in lung cancer liquid biopsies: Two sides of the same coin?
Christian Rolfo, Marco Giallombardo, Pablo Reclusa et al. (5 authors)
Lung Cancer Open Access
Published: Nov 2016
11 citations
2658 days before retraction
MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1
Lijun Zhao, Dongling Zou, Xueju Wei et al. (12 authors)
Tumor Biology
Published: Oct 2016
43 citations
2697 days before retraction
Direct determination of small RNAs using a biotinylated polythiophene impedimetric genosensor
Diego Voccia, Marta Sosnowska, Francesca Bettazzi et al. (11 authors)
Biosensors and Bioelectronics Open Access
Published: Sep 2016
60 citations
2719 days before retraction
Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and prevention
Bernhard Biersack
Non-coding RNA Research Open Access
Published: Jul 2016
47 citations
2771 days before retraction
Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Marco Giallombardo, Jorge Chacártegui Borrás, Marta Castiglia et al. (8 authors)
Journal of Visualized Experiments Open Access
Published: May 2016
54 citations
2833 days before retraction
Paper citing MicroRNA signatures of TRAIL resistance in human n...
Unknown Authors
Unknown Journal
Published: May 2016
2833 days before retraction
miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor
Fengyi Zhao, Jing Han, Xiewan Chen et al. (7 authors)
International Journal of Molecular Medicine Open Access
Published: May 2016
38 citations
2847 days before retraction
Potential Role of TRAIL in Metastasis of Mutant KRAS Expressing Lung Adenocarcinoma
Shyama Pal, Prayag J. Amin, Krishna B. Sainis et al. (4 authors)
Cancer Microenvironment Open Access
Published: Apr 2016
23 citations
2867 days before retraction
Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma
Edoardo D’Angelo, Matteo Fassan, Isacco Maretto et al. (9 authors)
Oncotarget Open Access
Published: Apr 2016
63 citations
2877 days before retraction
Mir-221/222 are promising targets for innovative anticancer therapy
Maria Teresa Di Martino, Marco Rossi, Daniele Caracciolo et al. (6 authors)
Expert Opinion on Therapeutic Targets
Published: Mar 2016
48 citations
2911 days before retraction
MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment
Kentaro Inamura, Yuichi Ishikawa
Journal of Clinical Medicine Open Access
Published: Mar 2016
169 citations
2912 days before retraction
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice
Simona Taverna, Marco Giallombardo, Ignacio Gil‐Bazo et al. (11 authors)
Oncotarget Open Access
Published: Feb 2016
105 citations
2927 days before retraction
Intercellular transfer of small RNAs from astrocytes to lung tumor cells induces resistance to chemotherapy
Assaf Menachem, Victoria Makovski, Or Bodner et al. (7 authors)
Oncotarget Open Access
Published: Feb 2016
26 citations
2941 days before retraction
Missing link between microRNA and prostate cancer
Balraj Singh Gill, Jimi Marin Alex, Navgeet Paul et al. (4 authors)
Tumor Biology
Published: Jan 2016
19 citations
2953 days before retraction
miR‐222 attenuates cisplatin‐induced cell death by targeting the <scp>PPP</scp>2R2A/Akt/<scp>mTOR</scp> Axis in bladder cancer cells
Liping Zeng, Zhengmao Hu, Kai Li et al. (4 authors)
Journal of Cellular and Molecular Medicine Open Access
Published: Jan 2016
78 citations
2959 days before retraction
Quick Stats
Total Citations: 296
Years Since Retraction: 1.7 year
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
MTA1 modulated by miR-30e contributes to epithelial-to-mese…
Oncogene • 36 citations
RNAi-mediated inhibition of cathepsin B and uPAR leads to d…
Oncogene • 150 citations
Inhibition of cathepsin B and MMP-9 gene expression in glio…
Oncogene • 306 citations
Downregulation of MMP-9 in ERK-mutated stable transfectants…
Oncogene • 103 citations
Blockade of cathepsin B expression in human glioblastoma ce…
Oncogene • 101 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice